Product Code: SR112024A2349
The global enteral feeding devices market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.
Enteral feeding devices refer to various tools and equipment used for the delivery of nutrients directly into the digestive tract through a feeding tube. This technique is primarily used for patients experiencing difficulties in the oral intake of food products, liquids and nutritional supplements. Some of the commonly used enteral feeding devices include feeding pumps, tubes, giving sets, enteral syringes and consumables. These devices enable consistent and accurate delivery of food containing proteins, carbohydrates, fats, water, minerals and vitamins. In comparison to the traditionally used polyvinylchloride feeding tubes, novel silicon-based variants are more flexible and do not cause irritation upon exposure to digestive enzymes.
The increasing prevalence of chronic diseases, such as diabetes, cancer and gastrointestinal ailments, is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population that is more susceptible to such medical illnesses is driving the market growth. Diseases and neurological conditions, such as multiple sclerosis, stroke and dementia, impact the patient's ability to swallow and cause malnourishment. This has enhanced the demand for enteral feeding devices that can aid in providing nutritional support through oral supplements and feeding tubes. In line with this, the advent of home enteral nutrition is also creating a positive outlook for the market. Additionally, various technological advancements, such as the development of low-profile gastrostomy buttons that are suitable for both children and adult patients, are contributing to the market growth. Other factors, including improving healthcare infrastructure, along with the growing demand for neonatal and preterm enteral feeding devices, are expected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global enteral feeding devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, age group, application and end user.
Breakup by Product Type:
Enteral Feeding Pumps
Enteral Feeding Tubes
Giving Sets
Enteral Syringes
Consumables
Others
Breakup by Age Group:
Adults
Pediatrics
Breakup by Application:
Oncology
Gastroenterology
Neurology
Diabetes
Hypermetabolism
Others
Breakup by End User:
Hospitals
Ambulatory Surgery Centers
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Amsino International Inc., B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), BD (Becton Dickinson and Company), Boston Scientific Corporation, Cardinal Health Inc., Conmed Corporation, Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA) and Moog Inc.
Key Questions Answered in This Report:
- How has the global enteral feeding devices market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global enteral feeding devices market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the age group?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global enteral feeding devices market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Enteral Feeding Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Enteral Feeding Pumps
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Enteral Feeding Tubes
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Giving Sets
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Enteral Syringes
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Consumables
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by Age Group
- 7.1 Adults
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Pediatrics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Oncology
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Gastroenterology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Neurology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Diabetes
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Hypermetabolism
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Ambulatory Surgery Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Amsino International Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG)
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 BD (Becton Dickinson and Company)
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Boston Scientific Corporation
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Cardinal Health Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Conmed Corporation
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA)
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 SWOT Analysis
- 15.3.9 Moog Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis